It's All About/Accredited Charity/Miami/Curing Type 1 Diabetes
Founded by parents determined to find a cure for their children with T1D, JDRF expanded through grassroots fundraising and advocacy efforts to become a powerhouse in the scientific community with more than 100 U.S. locations and six international affiliates. We’ve funded nearly $2 billion in research to date and made significant progress in understanding and fighting the disease. We must keep up the pace of funding so progress doesn’t slow or stop entirely. You’re the reason for our success. Every dollar we put toward research comes from donations. So when you support JDRF with your time, talent, voice and, yes, your money, you enable us to advance even more research. There are many ways to join the JDRF family, but for 45 years there has been only one reason—because we are the organization that will turn Type One into Type None. See full list of Video Credits http://broadcaster.beazil.net/public/credits/youtube/videos/41474 Miami city and its suburbs are located on a broad plain between the Florida Everglades to the west and Biscayne Bay to the east, which also extends from Florida Bay north to Lake Okeechobee. The elevation of the area never rises above 40 ft (12 m) and averages at around 6 ft (1.8 m) above mean sea level in most neighborhoods, especially near the coast. The highest undulations are found along the coastal Miami Rock Ridge, whose substrate underlies most of the eastern Miami metropolitan region. The main portion of the city lies on the shores of Biscayne Bay which contains several hundred natural and artificially created barrier islands, the largest of which contains Miami Beach and South Beach. The Gulf Stream, a warm ocean current, runs northward just 15 miles (24 km) off the coast, allowing the city’s climate to stay warm and mild all year. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Since its founding more than 40 years ago by parents of children affected by type 1 diabetes, the Juvenile Diabetes Research Foundation (JDRF) has been committed to finding a cure for all those individuals living with the disease. Today, JDRF acknowledges that this commitment will not likely be fulfilled in the near term. Although our ultimate goal—curing type 1 diabetes—remains unchanged, we are equally committed to better treating and preventing the disease. These goals aim to ensure that both children and adults living with type 1 diabetes remain healthy so that they can fully benefit from a cure when it becomes available. JDRF focuses on supporting the development and delivery of new therapies and devices that will ease the daily burden and challenges of managing type 1 diabetes and on the prevention of diabetes complications. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
This all centers round –
Blood Glucose Level,funding,insulinoma,neonatal diabetes,Glucagon-like peptide 1 agonists,patient self-monitoring of blood glucose,Dymelor,Glucose,low blood glucose,care delivery systems,cholesterol levels,therapeutic strategies,DKA,Lantus,speak out,support our research,Bolus insulin,fasting lipid profile,raise money,triglyceride,JDRFCC,Short Acting Insulin,Aaron Kowalski,Pre- Diabetes,make a contribution,become a volunteer,eAG,Neuropathy,blood pressure,The Promise Campaign,glycemic control comparison,cure therapies,CFRD,T1D Staging,impaired glucose tolerance,LDL cholesterol,Blood Glucose,cure,Levemir,make a tax-deductive donation,noninsulin treated patients,The Action to Control Cardiovascular Risk in Diabetes Study,Regular Acting Insulin,Long Acting Insulin,Political advocacy,Ketoacidosis,get involved,CGM,UKPDS Study,Clinical Trials,Estrogen in Type 1 Diabetes,monogenic diabetes syndrome,severe.